The Role of Diet and Lifestyle in Breast Cancer Survival (DietCompLyf)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00701584|
Recruitment Status : Unknown
Verified May 2014 by University College London Hospitals.
Recruitment status was: Active, not recruiting
First Posted : June 19, 2008
Last Update Posted : May 20, 2014
|Condition or disease|
Women matching the eligibility criteria are consented at breast cancer follow-up hospital visits. Blood and urine samples are then collected and questionnaires are provided for the participants to take away and return within 4 weeks. The process of sample collection and questionnaire provision is repeated for visit at years 3 and 5.
Year 2 and 4 study visit vary in that questionnaires including a 7 day food diary are sent to participants at home to be filled in 7 days before their scheduled follow-up appointment. At hospital, blood and urine samples are collected as usual.
|Study Type :||Observational|
|Actual Enrollment :||3390 participants|
|Official Title:||The Role of Diet, Complementary Treatment and Lifestyle in Breast Cancer Progression and Survival|
|Study Start Date :||January 2005|
|Actual Primary Completion Date :||August 2010|
|Estimated Study Completion Date :||December 2014|
- To assess the association between phytoestrogens and relapse free survival [ Time Frame: Up to 5 years post-diagnosis ]
- To assess the association between phytoestrogens and event free survival [ Time Frame: Up to 5 years post-diagnosis ]
- To assess the association between phytoestrogens and recurrence free survival [ Time Frame: Up to 5 years post-diagnosis ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00701584
|University of Westminster|
|London, United Kingdom, W1W 6UW|
|Principal Investigator:||Miriam V Dwek, PhD||University of Westminster|